Has Asad Fraser, MD received payments from drug or device companies?

Yes. Drug and device makers reported $706,597 in general payments to Asad Fraser, MD across 1,634 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Asad Fraser, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Asad Fraser, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Asad Fraser, MD

Rheumatology · Bowling Green, KYNPI 1497759286

Payments from drug & device makers

$706,597in general payments, 2019–2025

Across 1,634 payments — averaging $432.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$271K
Amgen$152K
Mallinckrodt Hospital Products Inc.$70K
GSK$60K
Pfizer$55K
Mallinckrodt Enterprises LLC$32K
plus $66K from 35 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	167	$270,874
Amgen(2 entities)	470	$152,351
Mallinckrodt Hospital Products Inc.	122	$70,436
GSK	115	$60,292
Pfizer	81	$54,814
Mallinckrodt Enterprises LLC	32	$31,920
Bristol Myers Squibb	34	$14,222
Takeda Pharmaceuticals U.S.A., Inc.	4	$12,078
Teva Pharmaceuticals USA, Inc.	6	$7,804
Johnson & Johnson(2 entities)	104	$6,322
UCB SA	4	$6,128
Kiniksa Pharmaceuticals, Ltd.	55	$4,976
AbbVie	101	$4,535
UCB, Inc.	118	$2,859
Eli Lilly	1	$2,000
Janssen Research & Development, LLC	2	$703
Lilly USA, LLC	35	$693
E.r. Squibb & Sons, L.L.C.	38	$623
Radius Health, Inc.	29	$536
AstraZeneca(2 entities)	20	$386
Janssen Scientific Affairs, LLC	3	$325
Sobi, Inc	12	$214
Organon	13	$206
Boehringer Ingelheim	10	$201
Aurinia Pharma U.S., Inc.	6	$164
Merck	12	$161
Sanofi	6	$133
Pacira Therapeutics, Inc.	7	$116
ANI Pharmaceuticals, Inc.	4	$103
Fresenius Kabi USA, LLC	6	$102
Genentech USA, Inc.	3	$53
Octapharma USA, Inc.	2	$51
Sanofi-aventis U.S. LLC	2	$40
Sandoz	2	$36
Antares Pharma, Inc.	2	$27
Kyowa Kirin, Inc.	1	$25
Almatica Pharma LLC	1	$22
United Therapeutics Corporation	1	$19
Pacira Pharmaceuticals Incorporated	1	$18
Gilead	1	$17
Actelion Pharmaceuticals US, Inc.	1	$14

How this compares

$706,597 in reported general payments places this provider in the 95th percentile of 81 rheumatology providers in Kentucky.

See all rheumatology providers in Kentucky →

Medicare billing

Part B allowed, 2024

$450,393

Medicare patients

438

Services billed

28,362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Bowling Green

Neha PansuriaBowling Green$39K
Jonathan HendrieBowling Green$3K
Jeffrey NealLexington$1.8M
Kishorkumar DesaiHopkinsville$1.3M
Alexander BrownLexington$614K
Timothy LoneskySomerset$328K
Housam SarakbiLouisville$297K
Paramarajan PiranavanLexington$283K
Rebecca CallisFlorence$272K
Daksha MehtaElizabethtown$234K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →